Midatech Pharma Phase I study of MTX-110 in rGB will continue with a planned dose escalation

Midatech Pharma Phase I study of MTX-110 in rGB will continue with a planned dose escalation

Related Keywords

United States ,American ,Dmitry Zamoryakhin ,Midatech Pharma ,American Medical Association ,Nasdaq ,Columbia University ,Data Safety Monitoring ,Temozolomide Alone ,Randomized Clinical ,American Medical ,